Rupeng Wang
Xinqiao, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
MG-K10, a Long-Acting Anti-IL-4 Receptor Alpha Monoclonal Antibody in Adult Patients with Moderate-to-Severe Atopic Dermatitis.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: November 05, 2025
Ivarmacitinib ointment in treatment of adults with mild-to-moderate atopic dermatitis: phase III of a randomized double-blind placebo-controlled phase II/III clinical trial.
Journal: The British journal of dermatology
Published: August 25, 2025
A Modified Hyaluronic Acid-Based Dissolving Microneedle Loaded With Daphnetin Improved the Treatment of Psoriasis.
Journal: Frontiers in bioengineering and biotechnology
Published: March 20, 2022
Efficacy and Safety of SHR0302, a Highly Selective Janus Kinase 1 Inhibitor, in Patients with Moderate to Severe Atopic Dermatitis: A Phase II Randomized Clinical Trial.
Journal: American journal of clinical dermatology
Published: July 06, 2021
Tazarotene/Betamethasone Dipropionate Cream in Patients with Plaque Psoriasis: Results of a Prospective, Multicenter, Observational Study.
Journal: Dermatology (Basel, Switzerland)
Published: July 17, 2020
Dermal Vγ4+T cells enhance the IMQ-induced psoriasis-like skin inflammatidon in re-challenged mice.
Journal: American journal of translational research
Published: February 05, 2017
Antitumor effects of recombinant human adenovirus-p53 against human cutaneous squamous cell carcinoma in mice.
Journal: Experimental and therapeutic medicine
Published: August 04, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026